MAK Capital Fund LP - 17 Jun 2025 SCHEDULE 13G Report for Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

Filing Manager
MAK Capital Fund LP
Reporting Manager
MAK Capital Fund LP
Security
Autolus Therapeutics plc Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
Symbol
AUTL
Shares outstanding
265,666,172 shares
Disclosed Ownership
15,408,638 shares
Ownership
5.8%
Form type
SCHEDULE 13G
Filing time
25 Jun 2025, 18:36:35 UTC
Date of event
17 Jun 2025
Next filing
03 Dec 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
MAK Capital Fund LP 5.8% 15,408,638 0 15,408,638 /s/ Michael A. Kaufman Managing Member
MAK Capital One L.L.C. 5.8% 15,408,638 0 15,408,638 /s/ Michael A. Kaufman Managing Member
Michael A. Kaufman 5.8% 15,408,638 0 15,408,638 /s/ Michael A. Kaufman MICHAEL A. KAUFMAN